药物信息为IMPLANON™ (etonogestrel implant) 68 mg (Organon USA Inc.): DESCRIPTION
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- INSTRUCTIONS FOR INSERTION AND REMOVAL
- INSERTION PROCEDURE
- REMOVAL PROCEDURE
- PATIENT LABELING
- 外部链接相关的IMPLANON™ (etonogestrel implant) 68 mg (Organon USA Inc.)
IMPLANON™ (etonogestrel implant) is an off-white, non-biodegradable, etonogestrel-containing single sterile rod implant for subdermal use. The implant is 4 cm in length with a diameter of 2 mm (see Figure 1). Each IMPLANON™ rod consists of an ethylene vinylacetate (EVA) copolymer core, containing 68 mg of the synthetic progestin etonogestrel (ENG), surrounded by an EVA copolymer skin. The release rate is 60–70 µg/day in week 5–6 and decreases to approximately 35–45 µg/day at the end of the first year, to approximately 30–40 µg/day at the end of the second year, and then to approximately 25–30 µg/day at the end of the third year. IMPLANON™ is a progestin-only contraceptive and does not contain estrogen. IMPLANON™ does not contain latex and is not radio-opaque.

Figure 1 (Not to scale) ENG [13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one], structurally derived from 19-nortestosterone, is the synthetic biologically active metabolite of the synthetic progestin desogestrel. It has a molecular weight of 324.46 and the following structural formula:

- Drug Information Provided by National Library of Medicine (NLM).
